Detection Technology - Q1 result in line, updated outlook
Q1 net sales at EUR 23.1m (+19.3% y/y) vs. EUR 22.3 m/22.6m Evli/consensus estimates. MBU sales were EUR 8.6m (EUR 8.8m our expectation) and SBU sales were EUR 14.5m (EUR 13.6m our expectation). DT’s Q1 EBIT came in at EUR 3.9m, which is in line with our estimates of EUR 4.1m (EUR 4.0m cons).
- Group level results: Q1 net sales amounted to EUR 23.1m (+19.3x% y/y) vs. EUR 22.3m/22.6m Evli/consensus estimates. Q1 EBIT was EUR 3.9m (16.7% margin) vs. EUR 4.1m/4.0m Evli/cons. R&D costs amounted to EUR 2.5m or 10.8% of net sales.
- Medical Business Unit (MBU) delivered net sales of EUR 8.6m which was in line with our estimate of EUR 8.8m. Net sales of MBU increased by 13.8% y/y due to continued good demand from key customers and successful shipments.
- Security and Industrial Business Unit (SBU) had net sales of EUR 14.5m vs. EUR 13.6m Evli estimate. SBU sales grew 22.9% y/y due to increased demand for security solutions.
- Updated outlook: sales of both business units will grow in line with the company's financial targets in the second quarter. The company expects demand to decline in the MBU business in the second half of 2019, as a significant customer will ramp down production of a device that uses DT's solution. Despite this, the company's total net sales are expected to grow in the second half of the year. There is uncertainty regarding demand, and the intensification of competition might be reflected in product prices.
- Medium-term business outlook is unchanged: Detection Technology aims to increase sales by at least 15% per annum and to achieve an operating margin at or above 15% in the medium term.